Hyaluronidase for Trigger Point Injection in Myofascial Pain Syndrome
NCT02293083
·
clinicaltrials.gov ↗
NA
Phase
COMPLETED
Status
61
Enrollment
OTHER
Sponsor class
Conditions
Myofascial Pain Syndrome
Interventions
DRUG:
trigger point injection
Sponsor
Samsung Medical Center